Sami Ali, M.D.
NPI 1821382250 · Hematology & Oncology Physician · Snellville, GA
Enrolled with Medicare as Practitioner - Medical Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1821382250
- Entity type
- Individual
- Primary specialty
- Hematology & Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- 276339 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
15 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
2 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
705 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 205 | $140 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232 | 100 | $83 |
| Administration of Chemotherapy Into Vein, 1 Hour Or Less96413 | 82 | $152 |
| Enhancing Oncology Model (eom) Monthly Enhanced Oncology Services (meos) Payment for Eom Enhanced ServicesM0010 | 82 | $95 |
| Infusion Into a Vein for Therapy, Prevention, Or Diagnosis, Additional Sequential Infusion, 1 Hour Or Less96367 | 76 | $33 |
| Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes99223 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 30 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Anastrozole | 90 | 28 |
| Ondansetronbrand: Ondansetron Odt | 51 | 35 |
| Letrozole | 48 | 13 |
| Pembrolizumabbrand: Keytruda | 31 | — |
| Enzalutamidebrand: Xtandi | 31 | — |
| Denosumabbrand: Xgeva | 31 | — |
| Abiraterone Acetate | 29 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$6,449 across 254 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 1513 S Grand Ave Ste 360Los Angeles, CA 90015-3465Phone: (213) 246-2422Fax: (213) 246-2019
Registry dates
- Enumerated
- 2011-06-02
- Last updated
- 2025-10-22
- Certified
- 2025-10-22
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.